Study types
- article 3
Condition tags
- endometriosis 3
- chronic_pelvic_pain 2
- dysmenorrhea 1
- dyspareunia 1
Top journals
Frequent coauthors
- Jimenez R 3
- Kristof Chwalisz 3
- Jiang P 3
- Joshua Burke 3
- Dmowski WP 3
- Carr B 3
- Chwalisz K 3
- Bruce R. Carr 3
- Chris O’Brien 3
- O'Brien C 3
This randomized double-blind study, with 24-week treatment and 24-week posttreatment periods, evaluated the effects of elagolix (150 mg every day, 75 mg twice a day) versus subcutaneous depot medroxyprogesterone acetate (DMPA-SC) on bone mi…
OBJECTIVE: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. METHODS: This was a phase II, randomized, placeb…
This Phase 2 study evaluated the safety and efficacy of elagolix for treating endometriosis-associated pain. A total of 155 women with laparoscopically confirmed endometriosis were randomized to placebo, elagolix 150 mg, or elagolix 250 mg …
Although adhesive capsulitis of the shoulder is a common clinical syndrome, adhesive capsulitis in other joints has rarely been reported. Four patients who developed adhesive capsulitis of the hip joint after trauma and two patients with ad…